Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|January 30, 1999
Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophilsD Vazifeh, A Bryskier, M T LabroAntimicrobial Agents and Chemotherapy|June 1, 1994
Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complexN Rastogi, K S Goh, A BryskierAntimicrobial Agents and Chemotherapy|June 13, 1998
In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in GermanyR R Reinert, A Bryskier, R LüttickenThe Journal of Antimicrobial Chemotherapy|November 1, 1990
Cefodizime, a new 2-aminothiazolyl cephalosporin: physicochemical properties, toxicology and structure-activity relationshipsA Bryskier, T Procyk, M T LabroAntimicrobial Agents and Chemotherapy|December 1, 1996
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampinK P Klugman, T Capper, A BryskierClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 7, 2004
Preparation of stock solutions of macrolide and ketolide compounds for antimicrobial susceptibility testsA Barry, A Bryskier, M Traczewski, et al.Pathologie-Biologie|June 1, 1986
[In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime]P Le Noc, A Bryskier, D Le NocThe Journal of Antimicrobial Chemotherapy|July 15, 1999
Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacinH B Drugeon, M E Juvin, A BryskierThe Journal of Antimicrobial Chemotherapy|October 6, 2000
Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complexP Bemer-Melchior, A Bryskier, H B DrugeonPathologie-Biologie|May 1, 1983
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]P Le Noc, A Bryskier, D Le NocPageof 12